These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3535545)

  • 1. Sedative or antimanic effects of carbamazepine and treatment of behavioral dyscontrol.
    Greenberg WM
    Am J Psychiatry; 1986 Nov; 143(11):1486-7. PubMed ID: 3535545
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1986 Apr; 143(4):519-22. PubMed ID: 3513634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of melancholia during carbamazepine treatment in borderline personality disorder.
    Gardner DL; Cowdry RW
    J Clin Psychopharmacol; 1986 Aug; 6(4):236-9. PubMed ID: 3525615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology of borderline personality disorder: a review.
    Cowdry RW
    J Clin Psychiatry; 1987 Aug; 48 Suppl():15-25. PubMed ID: 2886493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
    Cowdry RW; Gardner DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alprazolam-induced dyscontrol in borderline personality disorder.
    Gardner DL; Cowdry RW
    Am J Psychiatry; 1985 Jan; 142(1):98-100. PubMed ID: 2857071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical use of carbamazepine. Review of the literature and personal results].
    Botte L; Charles G
    Acta Psychiatr Belg; 1988; 88(3):181-94. PubMed ID: 3068954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathologic personality, temperament and treatment].
    Akiskal HS
    Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders.
    Okuma T
    Psychiatr Clin North Am; 1983 Mar; 6(1):157-74. PubMed ID: 6351033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines.
    Kutcher SP; Blackwood DH
    Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythema multiforme caused by carbamazepine].
    Steinmann C; Fric M; Laux G
    Psychiatr Prax; 2004 Nov; 31 Suppl 1():S147-8. PubMed ID: 15570535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral dyscontrol in borderline patients treated with amitriptyline.
    Soloff PH; George A; Nathan RS; Schulz PM; Perel JM
    Psychopharmacol Bull; 1987; 23(1):177-81. PubMed ID: 3602316
    [No Abstract]   [Full Text] [Related]  

  • 13. Response of borderline patients to loxapine and chlorpromazine.
    Leone NF
    J Clin Psychiatry; 1982 Apr; 43(4):148-50. PubMed ID: 7040351
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 15. Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders.
    Mackinnon DF; Pies R
    Bipolar Disord; 2006 Feb; 8(1):1-14. PubMed ID: 16411976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release carbamazepine capsules: a viewpoint.
    Weisler RH
    CNS Drugs; 2005; 19(8):717-8. PubMed ID: 16097854
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended-release carbamazepine capsules: a viewpoint.
    Mitchell PB
    CNS Drugs; 2005; 19(8):717-8. PubMed ID: 16097853
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic treatment in the borderline patient: advantages and techniques.
    Soloff PH
    J Clin Psychiatry; 1987 Aug; 48 Suppl():26-31. PubMed ID: 2886494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant effects of carbamazepine.
    Post RM; Uhde TW; Roy-Byrne PP; Joffe RT
    Am J Psychiatry; 1986 Jan; 143(1):29-34. PubMed ID: 3510572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.